Full Text OD-93-01 EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECTS NIH GUIDE, Volume 21, Number 44, December 11, 1992 RFA: OD-93-01 P.T. 02 Keywords: Cancer/Carcinogenesis Cardiovascular Diseases Blood Diseases Pulmonary Diseases Drugs/Drug Abuse Vision National Institutes of Health Letter of Intent Receipt Date: February 17, 1993 Application Receipt Date: March 30, 1993 PURPOSE Public Law Number 102-394, the Appropriations Act for the Department of Health and Human Services for Fiscal Year 1993, provides $4,960,000 in the budget of the Office of the Director, National Institutes of Health (NIH), for extramural facilities construction grants, to be awarded competitively. In response, the NIH is issuing a Request for Applications (RFA) OD-93-01 for the construction of facilities of urgent national importance for biomedical/behavioral research and/or services to support such research. Applications for construction grants that were submitted previously to the NIH may be resubmitted if the applicant wishes to recompete under this RFA. The main objective of this construction program is to facilitate the conduct of biomedical/behavioral research by providing funds for construction of new facilities and for the purchase of fixed research equipment essential for the operation of these facilities. Support may be requested for the construction of new facilities and additions or renovations to existing facilities to meet the biomedical/behavioral research and/or research support needs of an institution, or of a research group at that institution or elsewhere that utilizes the resources of that institution. The purpose of the proposed facility must be within the scope of one of the statutes authorizing the awards. Those statutes authorize construction grants for the National Cancer Program [Title IV, Section 413(b)(6)(B), PHS Act], construction grants for the National Heart, Blood Vessel, Lung and Blood Diseases and Blood Resources Program [Title IV, Section 421(b)(2)(B), PHS Act], construction grants for the vision research program of the National Eye Institute [Title IV, Section 455, PHS Act] construction grants for the NIH AIDS research programs [Title XXIII, Section 2351(a)(7)(B), PHS Act], and construction grants for the drug abuse, pharmacotherapeutic research program of the National Institute on Drug Abuse [Title IV, Section 464P(b)(3), PHS Act]. ELIGIBILITY REQUIREMENTS Domestic, non-Federal, public and private non-profit institutions, organizations, and associations that conduct or support biomedical/behavioral research are eligible to apply. An institution may submit only one application in response to this announcement. For example, a medical school and a dental school of the same institution, even if separated geographically, may not submit separate applications. MECHANISM OF SUPPORT The award mechanism will be the construction grant award (C06). Awards will be administered under Federal Regulation 45 CFR Part 74 - Administration of Grants, and for cancer construction projects, 42 CFR Part 52b will also apply. Up to 50 percent of the allowable costs of a project may be awarded, not to exceed $2,000,000 per award. Prior to grant award, the applicant must provide an assurance of required matching funds and that additional funds will be secured to meet any projected costs in excess of the award amount. Requests of less than $500,000 will not be accepted. FUNDS AVAILABLE This one-time solicitation based on the Fiscal Year 1993 appropriation provides $4,960,000 for this initiative. It is anticipated that three to four awards will be made. No indirect costs or continuation costs will be awarded. OBJECTIVES AND SCOPE Support may be requested for the costs of constructing non-Federal facilities to meet the biomedical/behavioral research, and/or services to support such research, needs of an institution or of a research group at that institution or elsewhere that utilizes the resources of that institution. The purpose of the proposed facility must be within the scope of one of the statutes authorizing the awards. Those statutes authorize construction grants that would benefit the fields of cancer, vision, heart, lung, and blood, AIDS research, and drug abuse, pharmacotherapeutic research. Associated fixed research equipment necessary for operation of these facilities may also be requested as part of the application. Instrumentation that usually would be requested as part of a research project will not be provided as part of this construction award. Facility construction that may be supported under this program includes: o Construction of new facilities o Additions to existing buildings o Completion of uninhabitable "shell" space in new or existing buildings o Major alterations and renovations LETTER OF INTENT Prospective applicants are asked to submit, by February 17, 1993, a letter of intent. The letter, requested for planning purposes only, should identify the RFA number noted above, the Principal Investigator, and include a brief title of the type(s) of research/research support to be conducted in the new facility. Although a letter of intent is not required, is not binding, and does not enter into the review of subsequent applications, the information that it contains allows NIH staff to estimate the potential workload and to avoid conflict of interest in the review. The letter of intent is to be addressed to: Mr. Kenneth Brow Chief, Research Facilities Branch Division of Cancer Biology, Diagnosis, and Centers National Cancer Institute Executive Plaza North, Room 300 Bethesda, MD 20892 Telephone: (30l) 496-8534 APPLICATION PROCEDURES o Intergovernmental-Review -- Executive Order 12372 Applicants are required to comply with Executive Order 12372 as supplemented by DHHS 45 CFR Part l00, Intergovernmental Review of Department of Health and Human Services Programs and Activities. Standard Form 424 meets the reporting requirements of Executive Order 12372. The purposes of this review are to: 1. Identify the relationship of any proposed project to State or area-wide comprehensive plans and evaluate the significance of these projects for the plans or programs of particular State agencies or local governments; and 2. Ensure that public agencies responsible for environmental standards and civil rights have an opportunity to review and comment upon proposed projects. Each applicant is encouraged to discuss projects with the Single Point of Contact (SPOC) at the earliest time possible and to provide the SPOC with required information in a timely manner. (The State Single Point of Contact List is included as an attachment in the special instructions accompanying the application Standard Form 424 package.) The SPOC must be given 60 days to review a construction grant application. Applications submitted to NIH in response to this solicitation must contain either SPOC comments or documentation indicating the date on which the application was submitted to the SPOC for review. The SPOC comment period ends 60 days after the application receipt date. Applicants are to provide the SPOC with a copy of the application NOT LATER THAN the time the application is submitted to the Division of Research Grants, NIH. Applicants required to submit applications for review to a Health Systems Agency (HSA), or Statewide Health Planning and Development Agency (SHPDA), must contact the SPOC/HSA/SHPDA to determine what coordination has been agreed to by those agencies. The NIH is required to notify the SPOC whenever an application is received without an indication that the application has been provided to the SPOC for review. All SPOC comments must be forwarded to both the applicant and to the NIH Institute to which the application is assigned. If comments are provided by the SPOC, the applicant may wish to submit to the NIH a statement of its reaction to the comments and any appropriate changes to its application. If no response is received from the SPOC by the end of the 60 days allotted for review of the application, the applicant must notify the NIH that no response was received. o Public Disclosure Applicants must also make a public disclosure of the project by publication and describe its environmental impact at the time the SPOC is notified. It is suggested that the notice be published in a large-circulation newspaper in the area. This public disclosure is required by Section 102 of the National Environmental Policy Act (NEPA) of l969 and by Federal Executive Order 11514. One example of a suitable disclosure statement follows: "PUBLIC NOTICE "Notice is hereby given that the Uptown Medical School proposes to construct additional space, partially utilizing Federal funds. The proposed construction project is the addition of 2,700 square feet connected to the existing Allen Building, which is located at 5333 Main Street, Downtown, Ohio." "The Medical School has evaluated the environmental and community impact of the proposed construction. There will be construction noise and increased construction traffic during the construction period, 1993-1994. No significant permanent environmental impacts are foreseen. All building permits and zoning approvals have been obtained." "In accordance with Federal Executive Order 11514, which implements the NEPA of 1969, any individual or group may comment on, or request information concerning, the environmental implications of the proposed project. Communications should be addressed to the Office of Planning, Uptown Medical School, and be received by (date). The Federal grant application may be reviewed at the Office of the Dean, School of Medicine, 5333 Main Street, during working hours." o Design Standards Design requirements are imposed to protect the health and safety of persons using the proposed facility, control the project's impact on the natural environment, conserve energy resources, achieve economy in construction costs, and protect against natural disasters such as earthquake and flood. Therefore, the documents listed under REFERENCES at the end of the RFA must be consulted, and the design requirements incorporated in the development, review, and evaluation of all drawings and specifications. Application Applicants must use Standard Form 424, Application for Federal Assistance. Application forms and special instructions for completing the forms relevant to this RFA must be requested from the staff contact official noted below. Those responsible for preparing the application are advised to consult with appropriate institutional officials before completing the application forms. An institution may submit only one application in response to this specific announcement. An original and two copies of the application including appendices must be submitted to: Application Receipt Office Division of Research Grants National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892** Applications must be received at NIH by March 30, 1993. To insure against carrier delays, retain a legible proof-of-mailing receipt from the carrier, dated no later than one week prior to the receipt date. Applications received after the receipt date will not be accepted for review in this competition and will be returned to the applicant. REVIEW CONSIDERATIONS Upon receipt, applications will be reviewed by NIH staff for completeness and responsiveness and to verify application and award eligibility. Those applications judged to be unresponsive, incomplete, or ineligible will be returned to the applicant. Applications that are complete and responsive will be reviewed for scientific and technical merit by appropriate special peer review group(s) that will be convened by the Division of Research Grants (DRG), NIH. The second level of peer review will be conducted by the National Advisory Board or National Advisory Council appropriate for the statutory authority that is applicable to the application, (i.e., the National Cancer Advisory Board, the National Heart, Lung, and Blood Advisory Council, the National Advisory Eye Council, the National Advisory Research Resources Council, or the National Advisory Council on Drug Abuse) in September 1993 to assess the relevance of all applications to the objectives described above. In addition, each application that receives a priority score will be reviewed by NIH staff and consultants for adherence to Government regulations and sound engineering practice. Final award decisions will be made by the Director, NIH. Awards will be made on or before September 30, 1993. Applications will be evaluated on the basis of criteria intended to assess the following overall questions: (1) How will the proposed change in the research environment facilitate the applicant's ability to conduct or support biomedical/behavioral research? (2) How will the proposed project meet national needs for biomedical/behavioral research and/or research support facilities? Thus, the reviewers will consider the following factors: o Appropriateness and suitability of the proposed facilities for the research to be conducted and/or research support to be provided. o The overall scope and quality of the ongoing biomedical/behavioral research or research support programs of the applicant institution, as well as the expanded or proposed future biomedical/behavioral research and/or research support activities. o The applicant's consideration of safety and biohazard issues in planning the construction and administering the facilities. o Specific deficiencies in the existing research facilities that would be remedied. o The proposed physical location and layout of the new facility. o Reasonableness of the proposed time-course and sequence for the construction. o Adequacy of the proposed administrative arrangements with respect to: --Institutional commitment to use the space for biomedical/behavioral research and/or research support. --Safety and biohazard issues. --Capabilities of the Principal Investigator and staff for scientific and fiscal administration of the facility. AWARD CRITERIA Conditions Advertisement for construction bids and construction can be initiated only after receipt of the construction grant award and subsequent approval of the working drawings and specifications by NIH staff. Therefore, consistent with Public Health Service policy, no requests to initiate construction will be entertained prior to receipt of a construction grant award from the NIH and subsequent approval of working drawings and specifications by NIH staff. The Principal Investigator should be a highly placed institutional official, at the level of Dean or equivalent, who has the responsibility for allocation of space for the program(s) of biomedical/behavioral research, and/or research support addressed in the submitted application. The facility must be utilized for the specific biomedical/behavioral research and/or research support purposes for which it was constructed for at least 20 years beginning 90 days following completion of the construction project. The NIH staff will evaluate use of the facility periodically to assure its continued use for the approved purposes. INQUIRIES For additional application information and application Standard Form 424 materials, contact: Mr. Kenneth Brow Chief, Research Facilities Branch Division of Cancer Biology, Diagnosis, and Centers National Cancer Institute Executive Plaza North, Room 300 Bethesda, MD 20892 Telephone: (301) 496-8534 For information concerning programmatic issues related to the construction program of the National Cancer Institute (NCI) contact Mr. Kenneth Brow at the address above. For information concerning fiscal matters related to NCI construction programs contact: Mrs. Kathy Hancock Grants Administration Branch Office of Administrative Management National Cancer Institute Executive Plaza South, Room 242 Bethesda, MD 20892 Telephone: (30l) 496-7800, Ext. 23 For information concerning programmatic issues related to the construction program of the National Heart, Lung and Blood Institute (NHLBI) contact: Dr. Ronald G. Geller Director, Division of Extramural Affairs National Heart, Lung and Blood Institute Westwood Building, Room 7A17 Bethesda, MD 20892 Telephone: (301) 496-7416 For information concerning fiscal matters related to the NHLBI construction program contact: Ms. Marie Willett Deputy Chief, Grants Operations Branch National Heart, Lung and Blood Institute Westwood Building, Room 4A12B Bethesda, MD 20892 Telephone: (301) 496-7255 For information concerning programmatic issues related to the construction program of the National Eye Institute (NEI) contact: Dr. Jack A. McLaughlin Associate Director, Extramural and Collaborative Program National Eye Institute Building 31, Room 6A04 Bethesda, MD 20892 Telephone: (301) 496-9110 For information concerning fiscal matters related to the NEI construction program contact: Ms. Gaye Lynch Chief, Grants Management Section Extramural Services Branch National Eye Institute Building 31, Room 6A52 Bethesda, MD 20892 Telephone: (301) 496-5884 For information concerning programmatic issues related to the AIDS Infrastructure Construction Program that will be administered by the National Center for Research Resources (NCRR) contact: Dr. Charles L. Coulter Director, Research Facilities Improvement Program National Center for Research Resources Westwood Building, Room 8A15 Bethesda, MD 20892 Telephone: (301) 496-8482 For information concerning fiscal matters related to the AIDS Infrastructure Construction Program contact: Ms. Katherine A. Springman Office of Grants and Contracts Management National Center for Research Resources Westwood Building, Room 849 Bethesda, MD 20892 Telephone: (301) 496-9840 For information concerning programmatic issues related to the drug abuse, pharmacotherapeutics research program of the National Institute on Drug Abuse contact: Ms. Eleanor Friedenberg Director, Office of Extramural Program Review National Institute on Drug Abuse 5600 Fishers Lane, Room 10-42 Rockville, MD 20857 Telephone: (301) 443-2755 For information concerning fiscal matters related to the NIDA construction program contact: Ms. Shirley A. Denney Chief, Grants Management Branch National Institute on Drug Abuse 5600 Fishers Lane, Room 8A-54 Rockville, MD 20857 Telephone: (301) 443-6710 AUTHORITY AND REGULATIONS All awards will be made under the authority of the Public Health Service Act, Title IV, Sections 413(b)(6)(B), 421(b)(2)(B), 455, 464P(b) (3) and Title XXIII, Section 2351(a)(7)(B) administered under PHS grants policies and Federal Regulations 45 CFR Part 74 and for cancer construction only, 42 CFR Part 52b. This program is described in the Catalog of Federal Domestic Assistance, Number 93.392, Cancer-Construction. REFERENCES A. PHS Policy. The project shall meet the PHS policies as described in the "Public Health Service Grants Policy Statement," current edition. B. The design of facilities to be constructed or altered with PHS grant funds will be evaluated for compliance with design requirements contained in the most recent edition of Technical andbook 2.1, "Information for Project applicants and State Agencies on Design and Construction Related Activities." The and book is part of the Department's Facilities Engineering and Construction Manual and is available from the Office of Engineering Services. Applicants from Regions I, II, III, and V should write to: Director of the Regional Office of Engineering Services Office of the Regional Health Administration, PHS Jacob K. Javits Federal Building 26 Federal Plaza New York, NY 10278 Applicants from Regions IV, VI, and IX should write to: Director of the Regional Office of Engineering Services Office of the Regional Health Administration, PHS 1200 Main Tower Dallas, TX 75202 Applicants from Regions VII, VIII, and X should write to: Director of the Regional Office of Engineering Services Office of the Regional Health Administration, PHS Blanchard Plaza Building 2201 6th Avenue Seattle, WA 98121 Where State and local codes or requirements exceed the design requirements set forth in Technical Handbook 2.1 or standards incorporated in it, the more stringent requirement will be applied. State or local codes may be used as a basis for facility design in lieu of the design requirements in Technical Handbook 2.1 but a prior determination must be made by HHS that the specific State or local code is equivalent to, or exceeds, HHS requirements. .
Return to NIH Guide Main Index
![]() |
Office of Extramural Research (OER) |
![]() |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |